The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient
NCT02588404 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2024-12-10
Summary
The objective of this study is to evaluate the predictive value of TMPRSS2-ERG gene fusion in patients with prostate cancer treated with radiation and hormonal therapy.
Conditions
Interventions
- DRUG
-
LHRH therapy
These patients will be treated with LHRH agonist as standard therapy.
Sponsors & Collaborators
-
Sir Mortimer B. Davis - Jewish General Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-12-31
- Primary Completion
- 2030-01-31
- Completion
- 2030-01-31
More Related Trials
-
Micro-RNA Expression Profiles in High Risk Prostate Cancer
NCT01220427 ·Status: TERMINATED
-
Evaluation of a Multimodal Strategy for Early Diagnosis of Men at High Genetic Risk of Prostate Cancer
NCT05333432 ·Status: WITHDRAWN ·Phase: NA
-
Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer
NCT05477823 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Transperineal, MRI-guided, Prostate Biopsy
NCT02651948 ·Status: COMPLETED ·Phase: PHASE4
-
Prostate Cancer Screening in Men With Germline BRCA2 Mutations
NCT02154672 ·Status: COMPLETED
-
Fusion Targeted Biopsy of the Prostate
NCT02013414 ·Status: COMPLETED ·Phase: NA
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
NCT05295407 ·Status: RECRUITING
-
Prostate Cancer Upgrading Reference Set
NCT02189486 ·Status: COMPLETED
-
MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue
NCT02680535 ·Status: COMPLETED ·Phase: NA
-
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer
NCT05241236 ·Status: RECRUITING
-
Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer
NCT01229618 ·Status: COMPLETED ·Phase: PHASE1
-
Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors
NCT04340245 ·Status: ACTIVE_NOT_RECRUITING
-
Focal MR-Guided Focused Ultrasound Treatment of Localized Low-Intermediate Risk Prostate Cancer: Feasibility Study
NCT01226576 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Transrectal Perilesional Biopsy in Diagnosis of Prostate Cancer
NCT06482658 ·Status: COMPLETED ·Phase: NA
-
MRI/MRSI in Risk Assessment of Prostate Cancer Patients
NCT00582543 ·Status: COMPLETED ·Phase: NA
-
Targeted And Perilesional Or Systematic Biopsy In Prostate Cancer
NCT07296042 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging
NCT05826470 ·Status: TERMINATED ·Phase: NA
-
Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
NCT07325721 ·Status: RECRUITING ·Phase: PHASE2
-
MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research
NCT02313623 ·Status: COMPLETED
-
Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the Prostate
NCT00585962 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer
NCT01354951 ·Status: TERMINATED ·Phase: PHASE2
-
Magnetic Resonance Imaging and Spectroscopy of the Prostate
NCT00590993 ·Status: COMPLETED
-
The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer
NCT00261456 ·Status: ACTIVE_NOT_RECRUITING
-
Timing of Post-prostatectomy PSMA Imaging
NCT05008900 ·Status: COMPLETED ·Phase: PHASE2
-
Precision-Based Genomics in Prostate Cancer
NCT04706663 ·Status: RECRUITING